Picture of Alzinova AB logo

ALZ — Alzinova AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln

BRIEF-Alzinova Resolves On Rights Issue Of SEK 51 Mln

- Alzinova AB ALZ.ST:

  • SAID ON THURSDAY RESOLVED TO CARRY OUT RIGHTS ISSUE OF UP TO 40,528,111 UNITS, CONTAINING SHARES, WARRANTS OF SERIES TO5 AND WARRANTS OF SERIES TO6

  • SUBSCRIPTION PRICE AMOUNTS TO SEK 1.26 PER UNIT, CORRESPONDING TO SEK 0.42 PER SHARE

  • MAIN PURPOSE OF IS TO FINANCE ONGOING CLINICAL PHASE 2 STUDY WITH ALZ-101 AND PROVIDE COMPANY WITH SUFFICIENT WORKING CAPITAL

  • UPON FULL SUBSCRIPTION ALZINOVA WILL RECEIVE ABOUT SEK 51 MILLION BEFORE ISSUE COSTS

  • UPON FULL SUBSCRIPTION AND FULL EXERCISE OF ALL WARRANTS OF SERIES TO5 AND TO6, COMPANY MAY RECEIVE AN ADDITIONAL CAPITAL INJECTION OF UP TO ABOUT SEK 203 MILLION DURING Q1 AND Q4 2027, RESPECTIVELY


Source text for Workspace: [nMFN2jzy0x ]
Further company coverage: ALZ.ST


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Alzinova AB

See all news